Skip to content
Home/Companies/HealthTech/Chronolife
Chronolife

Chronolife

HealthTech·France·Exited 2025·Held 8yr
Entry
2017
Hold
8yr
Exit
2025

Who owns Chronolife?

Chronolife is a French HealthTech company, now owned by TRAAK, which acquired it in 2025 from Ibionext.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Ibionext
Investor
Ibionext
iBionext Growth Fund · 2018 · VC

Key facts

HQFrance
SectorHealthTech
Websitechronolife.net
Exit Type
Trade Sale
Buyer
TRAAK
Exit Year
2025

More from iBionext Growth Fund

Other portfolio companies in the same fund.

T-Heart
Active
HealthcareFrance· 2018
BrainEver
Active
HealthcareFrance· 2017
GrAI Matter Labs
Exited 2023
TMTFrance· 2016
to Snap
Tilak Healthcare
Tilak Healthcare
Active
HealthTechFrance· 2016
Prophesee
Active
Deep TechFrance· 2014
Tissium
Active
MedTechFrance· 2013

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Chronolife?

Chronolife is now owned by TRAAK, which acquired it in 2025 from Ibionext.

When did TRAAK acquire Chronolife?

TRAAK acquired Chronolife in 2025, buying from Ibionext.

Who did Chronolife sell to?

Ibionext sold Chronolife to TRAAK in 2025 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue